Stefanos Theoharis

Chief Business Officer, Kiji Therapeutics

Stefanos, PhD, with more than 20 years of broad experience in the cell and gene therapy space, business development, program management, manufacturing and basic research brings a deep knowledge C&GT sector. Former CBO of Bone Therapeutics, Belgium-based company, developing specialized cell therapies for orthopaedic disorders. Pior to that he was Senior Vice-President at Cell Medica, and CBO at apceth GmbH. He also held positions as Head of Business Development at the antisense RNA drug specialist Antisense Pharma (now Isarna), and Director Business Development at Roche, focused on partnering activities in emerging science and technologies. Stefanos also worked at Lazard, the global investment bank, advising to a variety of life sciences firms on M&As and financing transactions.

Stevenage Bioscience Catalyst

30 November 2023